BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6942239)

  • 1. Long-term remission in acute lymphoid leukemia patients on maintenance chemoimmunotherapy.
    Eremeev VS; Rumyantsev AG; Akimova GV; Osipov SG; Kislyak NS; Bergolz VM
    Neoplasma; 1981; 28(2):219-21. PubMed ID: 6942239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoimmunotherapy of acute leukemia in children.
    Bergolz VM; Kisljak NS; Eremeev VS; Rumjanzev AG; Akimova GV; Molochkina AM; Osipov SG
    Neoplasma; 1978; 25(3):359-63. PubMed ID: 277786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
    Miale TD; Yocum D; Yocum C
    Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BCG and irradiated allogenic blast cells in maintenance chemotherapy of children with acute lymphoblastic leukemia in remission. A controlled study].
    Ortega JJ; Javier G
    Sangre (Barc); 1982; 27(3):349-57. PubMed ID: 6760428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Non-lymphoblastic acute leukaemia: maintenance therapy by trial of a combination of chemo- and immunotherapy (author's transl)].
    Sébahoun G; Gastaut JA; Imbert-Xeridat C; Favre R; Carcassonne Y
    Nouv Presse Med; 1979 Feb; 8(9):663-5. PubMed ID: 377219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of 3 protocols of treatment of acute lymphoid leukemia in children].
    Mathé G; de Vassal F; Schwarzenberg L; Delgado M; Weiner R; Gil MA; Pena-Angulo J; Belpomme D; Pouillart P; Machover D; Misset JL; Pico JL; Jasmin C; Hayat M; Schneider M; Cattan A; Amiel JL; Musset M; Rosenfeld C; Ribaud P
    Arch Fr Pediatr; 1977; 34(7):611-21. PubMed ID: 270966
    [No Abstract]   [Full Text] [Related]  

  • 7. Follow-up of the first (1962) pilot study of active immunotherapy of acute lymphoid leukaemia: a critical discussion.
    Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Hayat M; De Vassal F
    Biomedicine; 1977 Feb; 26(1):29-35. PubMed ID: 266407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BCG immunotherapy in children with acute lymphocytic leukemia in continuous remission after 3 years of intensive chemotherapy (protocol C-70) (author's transl)].
    Ortega JJ; Javier G
    Med Clin (Barc); 1982 Mar 1-15; 78(5):183-8. PubMed ID: 6952060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged survival in adults with acute myeloid leukemia treated with BCG immunotherapy].
    Vu Van H; Guyotat D; Fière D; Adeleine P; Gentilhomme O; Treille D; Imbert C; Coiffier B; Bryon PA; Viala JJ
    Nouv Presse Med; 1982 Dec; 11(49):3637-9. PubMed ID: 6962421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological control over the action of BCG vaccine in the chemoimmunotherapy of acute leukemia in children].
    Kisliak NS; Averbakh MM; Bergolts VM; Moroz AM; Eremeev VS
    Sov Med; 1978 Nov; (11):35-8. PubMed ID: 364684
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of immunotherapy of acute leukemias with BCG vaccine of Polish production].
    Kardaszewicz E; Japa J
    Acta Haematol Pol; 1975; 6(2):149-55. PubMed ID: 1057344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in acute leukemias. Possible applications in children.
    Mahoney DH; Starling KA
    Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoimmunotherapy of acute lymphoid leukemia in children].
    Eremeev VS; Rumiantsev AG; Akimova GV; Osipov SG; Kisliak NS
    Sov Med; 1980; (2):54-7. PubMed ID: 6928729
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administration of BCG-CWS for the treatment of leukemia in children.--Management of acute leukemia after cessation of maintenance chemotherapy-- (author's transl)].
    Ha K; Tawa A; Shu K; Ikeda T; Yabuuchi H; Nishida M
    Rinsho Ketsueki; 1980 Jun; 21(6):759-67. PubMed ID: 6936563
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
    Powles R; Toy JL
    Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy of acute infantile leukemia].
    De Bernardi B; Zanesco L; Carli M
    Minerva Med; 1972 Mar; 63(24):1468-70. PubMed ID: 4502510
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent data on the immunotherapy of leukemias].
    Mathe G; Schwarzenberg L; Amiel JL; Pouillart P; Hayat M; De Vassal F; Rosenfeld C; Jasmin C
    Recenti Prog Med; 1975 Oct; 59(4):314-29. PubMed ID: 769102
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of active immunotherapy of acute myeloid leukemia.
    Mathé G; Musset M; Schwarzenberg L; Hayat M; de Vassal F; Amiel JL; Pouillart P; Misset JL
    Biomedicine; 1975 Sep; 23(7):291-3. PubMed ID: 1066168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunology and immunotherapy of leukemia (basic results of 8-years research)].
    Bergol'ts VM
    Vopr Onkol; 1978; 24(11):16-24. PubMed ID: 283626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New experimental and clinical data on leukaemia immunotherapy.
    Mathé G; Schwarzenberg L; Amiel JL; Pouillart P; Hayat M; de Vassal F; Rosenfeld C; Jasmin C
    Proc R Soc Med; 1975 Apr; 68(4):211-6. PubMed ID: 1060146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.